Assessing the benefit of a replacement implantable cardioverter-defibrillator device for primary prevention of sudden cardiac death

Back

ESC Professional Premium Access

Assessing the benefit of a replacement implantable cardioverter-defibrillator device for primary prevention of sudden cardiac death

Session: Risk stratification in ventricular arrhythmias

Topic: Cardioversion and Defibrillation

Speaker: Professor A. Auricchio (Lugano, CH)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Professor Angelo Auricchio

Cardiocentro Ticino Institute, Lugano (Switzerland)

18 presentations

1 follower

4 more presentations in this session

Predicting ventricular arrhythmia inducibility in ajmaline-induced brugada type I pattern: validation of the dST-Tiso interval

Speaker: Doctor S. Iacopino (Cotignola, IT)

Access

Abstract

Slides

Implantable loop recorder monitoring in inherited cardiomyopathies: yield of clinically relevant arrhythmias

Speaker: Doctor A. Trancuccio (Pavia, IT)

Asymptomatic Brugada patients: long-term prognosis from a large prospective study.

Speaker: Associate Professor C. Giustetto (Turin, IT)

The use of wearable cardioverter defibrillator among patients suffering from myocarditis: data from a multicenter registry

Speaker: Doctor I. El-Battrawy (Bochum, DE)

Access the full session

Risk stratification in ventricular arrhythmias

Speakers: Professor A. Auricchio, Doctor S. Iacopino, Doctor A. Trancuccio, Associate Professor C. Giustetto, Doctor I. El-Battrawy

Access

Video

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources